Navigation Links
A new link between stem cells and tumors

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Cient�fic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells. The study, reported this week in the on-line edition of Nature Genetics (September 4) shows that if key molecules aren't placed in the right locations within stem cells before they divide, the result can be deadly tumors.

Cells in the very early embryo are interchangeable and undergo rapid division. Soon, however, they begin differentiating into more specific types, finally becoming specialized cells like neurons, blood, or muscle. As they differentiate, they should stop dividing and usually become embedded in particular tissues. Some tumor cells are more like stem cells because they are identical, they divide quickly, and in the worst case ?metastasize ?they wander through the body and implant themselves in new tissues.

Specialized cells may die through age or injuries, so the body keeps stocks of stem cells on hand to generate replacements. Usually the stem cell divides into two types: one that is just like the parent, which is kept to maintain the stock, and another that differentiates. This is what happens with neuroblasts. Cell division creates one large neuroblast and a smaller cell that can become part of a nerve. This process is controlled by events that happen prior to division. The parent cell becomes asymmetrical: it collects a set of special molecules, including Prospero and other proteins, in the area that will bud off and become the specialized cell.

"This asymmetry provides the new cell with molecules it needs to launch new genetic programs that tell it what to become," says Cayetano Gonz�lez, whose group began the project at EMBL and has continued the work as they moved to the IRBB-PCB. "The current study investigates what happens when the process of localizi ng these molecules is disturbed."

Whether Prospero and its partners get to the right place depends on the activity of specific genes in the stem cell. EMBL PhD student Emmanuel Caussinus from Gonz�lez's group created neuroblasts in which these genes were disrupted. "We no longer had normal neuroblasts and daughter cells capable of becoming part of a nerve," Caussinus says. "Instead, we had a tumor."

When these altered cells were transplanted into flies, the results were swift and dramatic. The tissue containing the altered cells grew to 100 times its initial size; cells invaded other tissues, and death followed. The growing tumor became "immortal", Caussinus says; cells could be retransplanted into new hosts for years, generation after generation, with similar effects.

The study proves that specific genes in stem cells ?those which control the fates of daughter cells ?are crucial. If such genes are disrupted, the new cells may no longer be able to control their reproduction, and this could lead to cancer. "It puts the focus on the events that create asymmetrical collections of molecules inside stem cells," Gonz�lez says. "This suggests new lines of investigation into the relationship between stem cells and tumors in other model organisms and humans."


'"/>

Source:European Molecular Biology Laboratory


Related biology news :

1. Variation in womens X chromosomes may explain differences among individuals, between sexes
2. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
3. Study reveals dramatic difference between breast cancers in US and Africa
4. Molecular fossils uncover link between viruses and the immune system
5. Research may provide new link between soft drinks and weight gain
6. A new molecule discovered in the battle between plants and disease
7. Underground tunnels discovered as means for communication between immune system cells
8. New discovery blurs distinction between human cells and those of bacteria
9. Plants discriminate between self and non self
10. Genetic link confirmed between Polynesians and indigenous Taiwanese
11. European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: